118
117 119
118 120
119 121
120 122
121 123
122 125
123 126
124 127
125 128
126 129
127 130
128 131
129 132
130 133
131 134
132 135
133 136
134 137
135 138
136 139
137 140
138 141
139 142
140 143
141 144
142 145
143 146
144 147
145 148
146 149
147 150
148 151
149 152
150 153
151 154
152 155
153 156
154 157
155 158
156 159
157 160
158 161
159 162
160 163
161 164
162 165
163 166
164 167
165 168
166 169
167 170
168 171
169 172
170 173
171 174
172 175
173 176
174 177
175 179
176 180
177 181
178 182
179 183
180 184
181 185
182 186
183 187
184 188
185 189
186 190
187 191
188 192
189 193
190 194
191 195
An Introduction to Testing for Drugs of Abuse
William E. Schreiber
Clinical Director of Chemistry, LifeLabs
Professor, Department of Pathology and Laboratory Medicine
The University of British Columbia
Vancouver, Canada
This edition first published 2022 © 2022 John Wiley & Sons Ltd
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.
The right of William E. Schreiber to be identified as the author of this work has been asserted in accordance with law.
Registered Offices John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial Office 9600 Garsington Road, Oxford, OX4 2DQ, UK
For details of our global editorial offices, customer services, and more information about Wiley products
